Sexual dimorphism of G protein-coupled receptor signaling in the brain  

作　　者：Sara Aljoudi Hamdan Hamdan Khaled S.Abd-Elrahman 

机构地区：[1]Department of Physiology and Immunology,College of Medicine and Health Sciences,Khalifa University,Abu Dhabi,United Arab Emirates [2]Healthcare Engineering Innovation Center(HEIC),Khalifa University,Abu Dhabi,United Arab Emirates [3]Department of Anesthesiology,Pharmacology and Therapeutics,and Djavad Mowafaghian Center for Brain Health,University of British Columbia,Vancouver,BC,Canada [4]Department of Pharmacology and Therapeutics,College of Medicine and Health Science,Khalifa University,Abu Dhabi,United Arab Emirates [5]Department of Pharmacology and Toxicology,Faculty of Pharmacy,Alexandria University,Alexandria,Egypt

出　　处：《Neural Regeneration Research》2024年第8期1635-1636,共2页中国神经再生研究（英文版）

基　　金：supported by a New Investigator grant fram the Alzheimer’s Society of Canada and Alzheimer Disease Research Grant from Djavad Mowafaghian Centre for Brain Health(to KSAE)。

摘　　要：G protein-coupled receptors(GPCRs)represent the most substantial family of membrane receptors that are targeted by U.S.Food and Drug Administration-approved drugs.Much of the preclinical research to understand the pharmacology of many membrane receptors including GPCRs is derived from studies in male animal models(Karp and Reavey,2019).

关 键 词：DRUGS CLINICAL TARGETED 

分 类 号：R96[医药卫生—药理学]